This trial is active, not recruiting.

Condition colon cancer
Sponsor Memorial Sloan Kettering Cancer Center
Collaborator National Cancer Institute (NCI)
Start date February 1981
End date January 2017
Trial size 110 participants
Trial identifier NCT00591279, 81-035


This study evaluates strategies for the surveillance of post-polypectomy patients for the control of bladder cancer

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Barium enema and colonoscopy at one and three years after entry.
Barium enema and colonoscopy at three years only after entry.

Primary Outcomes

evaluate strategies for the surveillance of post-polypectomy patients
time frame: 6 years

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - referral for colonoscopy or - referral for proctoscopy or for a complete colonoscopy after a proctoscopy or flexible sigmoidoscopy Exclusion Criteria: - prior history of colon cancer, unrelated polypectomy, inflammatory bowel disease, family history of familial polyposis

Additional Information

Official title Cancer Control Following Polypectomy
Principal investigator Sidney Winawer, MD
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center.